CAMBRIDGE, England & BRISTOL, Pa.--(BUSINESS WIRE)--Abzena plc, the life sciences group providing services and technologies to enable the design, development and manufacture of biopharmaceutical ...

SAN DIEGO--(BUSINESS WIRE)--Abzena, the leading biotherapeutics target to GMP partner research organization (PRO) announced an accelerated program to IND. This reduces timeline from stable pool to GMP ...

Life sciences contract development and manufacturing organization (CDMO) Abzena will invest $213 million to establish a new manufacturing operation in Sanford, NC. Abzena, a life sciences contract ...

CDMO Abzena reports that it has invested $60m into a new facility for late phase and commercial cGMP manufacturing. The new ~50,000 sq ft Lusk Blvd. facility at the company’s site in San Diego ...

Abzena has acquired contract development and manufacturing organization (CDMO) PacificGMP for $8.4 million, the companies said today, in a deal that gives the buyer a U.S. base of operations while ...

Roughly one year after dropping designs on a $200 million biologics plant in North Carolina, antibody-drug conjugate specialist Abzena has snared a fresh round of funding to overhaul manufacturing on ...

Cambridge, UK, 24 November 2015 - Abzena plc (AIM:ABZA, 'Abzena' or the 'Group'), a life sciences group providing services and technologies enabling the development and manufacture of ...

Pfizer Inc. and Abzena have entered into an agreement under which Pfizer will acquire Abzena’s manufacturing facility in Sanford, NC. Upon completion of the construction, the state-of-the-art facility ...

Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Continuous Manufacturing Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Drug Molecule, Stage of Bioprocessing, Type ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

(MENAFN- GlobeNewsWire - Nasdaq) The continuous manufacturing market offers key growth opportunities in streamlining pharmaceutical production by reducing costs, minimizing downtime, and enhancing ...